Search Results - "VALENZUELA, FERNÁN GÓMEZ"
-
1
The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition
Published in Frontiers in oncology (10-06-2021)“…The tumor microenvironment (TME) corresponds to a complex and dynamic interconnection between the extracellular matrix and malignant cells and their…”
Get full text
Journal Article -
2
Cyclooxygenase‐2 protein expression modulates cell proliferation and apoptosis in solid ameloblastoma and odontogenic keratocyst. An immunohistochemical study
Published in Journal of oral pathology & medicine (01-10-2021)“…Background Cyclooxygenase‐2 protein is a critically important mediator in inflammation that influences proliferation, apoptosis, angiogenesis and metastasis…”
Get full text
Journal Article -
3
The Challenge by Multiple Environmental and Biological Factors Induce Inflammation in Aging: Their Role in the Promotion of Chronic Disease
Published in Frontiers in immunology (14-10-2020)“…The aging process is driven by multiple mechanisms that lead to changes in energy production, oxidative stress, homeostatic dysregulation and eventually to…”
Get full text
Journal Article -
4
Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway
Published in International journal of molecular sciences (21-08-2022)“…Muscle and bone are tightly integrated through mechanical and biochemical signals. Osteoclasts are cells mostly related to pathological bone loss; however,…”
Get full text
Journal Article -
5
Immunohistochemical evaluation of cyclin D1 and p63 in odontogenic keratocyst and unicystic ameloblastoma
Published in Revista española de patología (01-10-2024)“…Odontogenic keratocyst (OKC) and unicystic ameloblastoma (UA) are lesions of odontogenic origin. Both lesions are morphologically cysts. However, they are…”
Get more information
Journal Article -
6
Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma
Published in Revista española de patología (01-07-2023)“…Oral squamous cell carcinoma (OSCC) is the most prevalent head and neck cancer. Few studies have analyzed the expression of proteins related to inflammation…”
Get more information
Journal Article -
7
Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts
Published in Journal of clinical and experimental dentistry (01-02-2023)“…The growth of ameloblastomas (odontogenic tumours) and odontogenic keratocyst (OKC) (developmental cyst) is associated with the expression of proteins related…”
Get full text
Journal Article -
8
CYCLOOXYGENASE-2 AND ANGIOGENESIS IN ORAL SQUAMOUS CELL CARCINOMA: AN IMMUNOHISTOCHEMICAL STUDY
Published in Oral surgery, oral medicine, oral pathology and oral radiology (01-01-2020)“…Cyclooxygenase-2 (cox-2) overexpression is linked to carcinogenesis and maintenance of progressive tumor growth. Angiogenesis plays a crucial role in…”
Get full text
Journal Article -
9
ADENOMATOID ODONTOGENIC TUMOR. A CLINICAL-PATHOLOGIC STUDY OF 27 CASES
Published in Oral surgery, oral medicine, oral pathology and oral radiology (01-01-2020)“…Adenomatoid odontogenic tumor (AOT) is a benign (hamartomatous), noninvasive lesion with slow but progressive growth. The 3 variants—follicular,…”
Get full text
Journal Article -
10
Odontogenic tumours in a Chilean population: a retrospective study of 544 cases based on 2022 WHO classification
Published in Medicina oral, patología oral y cirugía bucal (01-11-2023)“…Odontogenic tumours are infrequent lesions. Studies on the frequency of odontogenic tumours from Latin America are scarce. This work aimed to determine the…”
Get full text
Journal Article -
11
Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer
Published in Cancers (22-12-2023)“…Chronic inflammation influences the tumor immune microenvironment (TIME) in high-grade serous ovarian cancer (HGSOC). Specifically, cyclooxygenase-2 (COX-2)…”
Get full text
Journal Article -
12
Abstract 182: Cyclooxygenase-2 blockade is crucial to restore natural killer cell activity before anti-CTLA-4 therapy against high-grade serous ovarian cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Objective: Here our goal was to evaluate the impact of the immunosuppressive enzyme cyclooxygenase-2 (COX-2) expression on the immune effector capacity against…”
Get full text
Journal Article